Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
oltipraz
Description:
Oltipraz is a synthetic chemical compound studied as a drug for parasitic infections and as a potential chemopreventive agent.
Related topics:
Genomics, phytochemicals, and oxidative stress (16%),
Parasites and Host Interactions (11%),
Pharmacogenetics and Drug Metabolism (10%)
Wikidata ID:
wiki/Q7088765
OpenAlex ID:
keywords/oltipraz
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
2001
·
Minerva Ramos-Gomez
, Mi-Kyoung Kwak
, et al.
·
Proceedings of the National Academy of Sciences
·
1,122
The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
2001
·
M McMahon
, K Itoh
, et al.
·
PubMed
·
651
Nrf2 as a novel molecular target for chemoprevention
2004
·
Jeong-Sang Lee
, Young-Joon Surh
·
Cancer Letters
·
520
Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.
1990
·
C W Boone
, G J Kelloff
, et al.
·
PubMed
·
400
Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis
2004
·
Katsuyuki Iida
, Ken Itoh
, et al.
·
Cancer Research
·
375
PDF
Role of Transcription Factor Nrf2 in the Induction of Hepatic Phase 2 and Antioxidative Enzymes in vivo by the Cancer Chemoprotective Agent, 3H-1, 2-Dithiole-3-thione
2001
·
Mi-Kyoung Kwak
, Ken Itoh
, et al.
·
Molecular Medicine
·
361
PDF
Activation and detoxication of aflatoxin B1
1998
·
F.Peter Guengerich
, William W. Johnson
, et al.
·
Mutation research. Fundamental and molecular mechanisms of mutagenesis
·
354
Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor-E2–related factor-2 transcriptional pathway
2007
·
Jonathan M. Maher
, Matthew Z. Dieter
, et al.
·
Hepatology
·
324
PDF
Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes
2006
·
Emilie Jigorel
, Marc Le Vee
, et al.
·
Drug Metabolism and Disposition
·
323
Protective Alterations in Phase 1 and 2 Metabolism of Aflatoxin B1 by Oltipraz in Residents of Qidong, People's Republic of China
1999
·
J.-S. Wang
, X. Shen
, et al.
·
JNCI Journal of the National Cancer Institute
·
310
Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones
2003
·
E. Christine Pietsch
, Jefferson Y. Chan
, et al.
·
Journal of Biological Chemistry
·
288
Induction of the Multidrug Resistance-associated Protein Family of Transporters by Chemical Activators of Receptor-mediated Pathways in Mouse Liver
2005
·
Jonathan M. Maher
, Xingguo Cheng
, et al.
·
Drug Metabolism and Disposition
·
264
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones
2001
·
Mi-Kyoung Kwak
, Patricia A. Egner
, et al.
·
Mutation research. Fundamental and molecular mechanisms of mutagenesis
·
242
Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
1987
·
T W Kensler
, P A Egner
, et al.
·
PubMed
·
240
Identification of BCRP as transporter of benzo[ a ]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists
2005
·
Bettina Ebert
, Albrecht Seidel
, et al.
·
Carcinogenesis
·
236
Primary prevention of hepatocellular carcinoma in developing countries
2000
·
Christopher P. Wild
, Andrew J. Hall
·
Mutation Research/Reviews in Mutation Research
·
230
Chemoprevention by Inducers of Carcinogen Detoxication Enzymes
1997
·
T W Kensler
·
Environmental Health Perspectives
·
229
Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism
1997
·
M. Manson
, H W Ball
, et al.
·
Carcinogenesis
·
226
Chemopreventive drug development: perspectives and progress.
1994
·
G J Kelloff
, C W Boone
, et al.
·
PubMed
·
209
Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice
2003
·
M. Ramos-Gomez
, Patrick M Dolan
, et al.
·
Carcinogenesis
·
203
Detoxication Enzymes and Chemoprevention
1997
·
J. Wilkinson
, M. L. Clapper
·
Experimental Biology and Medicine
·
197
Potent Protection against Aflatoxin-Induced Tumorigenesis through Induction of Nrf2-Regulated Pathways by the Triterpenoid 1-[2-Cyano-3-,12-Dioxooleana-1,9(11)-Dien-28-Oyl]Imidazole
2006
·
Melinda S. Yates
, Mi-Kyoung Kwak
, et al.
·
Cancer Research
·
193
Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
1996
·
M J Wargovich
, C D Chen
, et al.
·
PubMed
·
183
Induction of Phase I and Phase II Drug-Metabolizing Enzyme mRNA, Protein, and Activity by BHA, Ethoxyquin, and Oltipraz
1995
·
T.M. Buetler
, E.P. Gallagher
, et al.
·
Toxicology and Applied Pharmacology
·
182
Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice
2010
·
Z. Yu
, W. Shao
, et al.
·
Diabetologia
·
174
PDF
Show more works
View as search
Works count:
609
Citation count:
24,890
Year
Topic
Type